India’s rupee defence faces tough test as capital flows stallIndia’s rupee faces sustained pressure as weak capital inflows and elevated oil prices strain the balance of payments. Despite RBI interven...
30 Apr, 2026, 08.47 AM IST
India's generic drug prescription mandate faces execution challenges, says FitchThe Indian government's mandate for physicians to prescribe only generic drug names is facing challenges in execution, according to Fitch R...
24 Aug, 2023, 02.50 PM IST
Bharat Biotech claims 77.8% efficacy of Covaxin in phase-3 trialsAnnouncing the much awaited safety and efficacy data from phase-3 clinical trials of Covaxin, the IMCR director Prof Balram Bhargava said C...
03 Jul, 2021, 09.15 AM IST
Chinese companies considers mixing vaccines, booster shotsSinovac and Sinopharm, the two Chinese manufacturers that combined have exported hundreds of millions of doses all over the world, say they...
28 Apr, 2021, 06.43 PM IST
Low efficacy of China’s vaccines sparks a stir on social mediaGeorge Fu Gao, head of the Chinese Center for Disease Prevention and Control, said at a forum on Saturday that something needed to be done ...
12 Apr, 2021, 04.51 PM IST
Pakistan approves emergency use of third Chinese COVID-19 vaccine despite low efficacy rateThe Drug Regulatory Authority of Pakistan (DRAP) on Thursday granted Emergency Use Authorisation (EUA) to CoronaVac, developed by Chinese c...
10 Apr, 2021, 12.32 PM IST
Pakistan approves emergency use of third Chinese COVID vaccine, despite its low efficacy rateCiting officials, Geo News reported that the Drug Regulatory Authority of Pakistan (DRAP) has granted Emergency Use Authorization (EUA) to ...
09 Apr, 2021, 02.18 PM IST
Bharat Biotech's corona vaccine Covaxin 81% effectiveThe trials involved 25,800 participants and was conducted in partnership with the Indian government's medical research body.
03 Mar, 2021, 08.52 PM IST
More jabs on way: Three candidates to file final data, launch phase-3 trialsBiological E, Dr Reddy’s Laboratories and Serum Institute of India are preparing to submit data for approval of their Covid-19 vaccines or ...
24 Feb, 2021, 09.34 AM IST
Covaxin COVID-19 vaccine's Phase III trial doesn't have enough takers, which could delay its roll out to the massesThe rollout of the Covid-19 vaccine by Bharat Biotech for the general public may get delayed as the All India Institute of Medical Sciences...
18 Dec, 2020, 12.14 PM IST
AstraZeneca partner sticks with two full dose regimen in Covid trials in IndiaThe British drugmaker has said its Covid-19 vaccine could be up to 90% effective if administered as a half dose followed by a full dose, bu...
01 Dec, 2020, 10.55 PM IST
Where are we in the COVID-19 vaccine race?AstraZeneca said on Nov. 23 it will immediately prepare the data to submit to regulatory authorities around the world that offer conditiona...
30 Nov, 2020, 06.02 PM IST
AstraZeneca likely to run additional global vaccine test, CEO Pascal Soriot says“Now that we’ve found what looks like a better efficacy we have to validate this, so we need to do an additional study,” CEO Pascal Soriot ...
26 Nov, 2020, 10.38 PM IST
Where are we in the COVID-19 vaccine race?U.S. drugmaker Pfizer Inc and German partner BioNTech SE released final late-stage trial data on Nov. 18 that showed their shot was 95% eff...
24 Nov, 2020, 05.33 PM IST
India slowdown fast broadening into weakening of consumption: Moody’sMoody’s said weak household consumption would curb growth, broadly weighing on credit quality.
16 Dec, 2019, 01.35 PM IST
Raghuram Rajan gets Deutsche Bank award for fin and economic researchRaghuram Rajan got prize in recognition of his ground-breaking research work which has influenced financial and macro-economic policies aro...
27 Sep, 2013, 04.26 PM IST
- Centre may fix micro fin interest rates
The government is planning to prescribe broad interest rate bands for micro finance institutions (MFIs) and self-help groups.
10 Jan, 2007, 02.00 AM IST